Respiratory Tract Infections clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

    “Pass on what's important: You’ll give them love in lots of ways. Could protection from RSV be one of them?”

    open to eligible females ages 0-49

    This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.

    Palo Alto, California and other locations